chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Hepatic enzyme, Hepatic enzyme increased, Hyperhidrosis
Clinical narrative: shaking; sweating; numbness in legs; Liver enzymes high; shortness of breath; Headache; vomiting; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP7534), dose 1 via an unspecified route of administration, administered in Arm Left on 18Mar2021 13:30 (at the age of 51years) as dose 1, single for Covid-19 immunization. Medical history included high blood pressure, CRPS (complex regional pain syndrome), fibromyalgia, migraines, osteoarthritis, and known allergies: most antidepressants, arthritis meds. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included lisinopril (LISINOPRIL) and pantoprazole (PANTOPRAZOLE); both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 (15:30), the patient experienced headache, vomiting, shaking, sweating, numbness in legs, shortness of breath, liver enzymes high. The patient had 2 trips to ER (Emergency room) and numerous tests. The adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient was treated with IV's (intravenous-as reported) and vomiting medications so far. The patient had a Covid test post vaccination. Covid test type post vaccination: Nasal Swab on 20Mar2021. Covid test result: Negative; Covid test date:03Apr2021; Covid test type post vaccination: Nasal Swab; Covid test result: Negative. The outcome of events was not recovered.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Laboratory test, SARS-CoV-2 test, Tremor, Vomiting
Clinical narrative: shaking; sweating; numbness in legs; Liver enzymes high; shortness of breath; Headache; vomiting; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP7534), dose 1 via an unspecified route of administration, administered in Arm Left on 18Mar2021 13:30 (at the age of 51years) as dose 1, single for Covid-19 immunization. Medical history included high blood pressure, CRPS (complex regional pain syndrome), fibromyalgia, migraines, osteoarthritis, and known allergies: most antidepressants, arthritis meds. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included lisinopril (LISINOPRIL) and pantoprazole (PANTOPRAZOLE); both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 (15:30), the patient experienced headache, vomiting, shaking, sweating, numbness in legs, shortness of breath, liver enzymes high. The patient had 2 trips to ER (Emergency room) and numerous tests. The adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient was treated with IV's (intravenous-as reported) and vomiting medications so far. The patient had a Covid test post vaccination. Covid test type post vaccination: Nasal Swab on 20Mar2021. Covid test result: Negative; Covid test date:03Apr2021; Covid test type post vaccination: Nasal Swab; Covid test result: Negative. The outcome of events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lymphadenopathy, Mass, Pyrexia
Clinical narrative: fever 102 and a large node (developed quite large, visible to the naked eye, red 2 centimeters supra clavicular node; fever 102 and a large node (developed quite large, visible to the naked eye, red 2 centimeters supra clavicular node; 2 cm supraclavicular node that she has developed; This is a Spontaneous report from a contactable Nurse. A 28-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, (Batch/Lot Number: ER8727)), dose 2 via an unspecified route of administration on 26Mar2021 17:00 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, (Batch/Lot Number: EN6203)), on 06Mar2021 for covid-19 immunisation. On an unspecified date, the patient woke up next morning with a fever 102 and a large node (developed quite large, visible to the naked eye, red 2 centimeters supra clavicular node). Caller stated I know that they are reports that women should not go through mammograms after receiving the vaccine, described the location of the node as almost shoulder height, way above the clavicle, stated that it developed next day (after vaccination) and she was wondering if there are reports of such a reaction. Stated that a node gotten smaller but still easily palpable, it went probably from 2 centimeters down to 1 centimeter, so it was probably half the size. stated that she did not feel it today, but she palpated it yesterday and it was down probably half the size. reporter stated, Yes, we know that fever was, what we are following about was 2 cm supraclavicular node that she has developed. Reporter stated that she wants the first or just the second dose when she had the reaction. Limited information was available over the call. The patient underwent lab tests and procedures which included body temperature was 102 on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on neck, chest, shoulder.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 04Apr2021 at 17:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer, pre-diabetic from an unspecified date. It was unknown if the patient had any allergy. Concomitant medications included amlodipine besilate (AMLODIPINE BESYLATE) 10 mg from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 22:00 the patient experienced hives on neck, chest, shoulder. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypersomnia, Nasopharyngitis, Neck pain
Clinical narrative: Extreme tiredness/fatigue; Sleeping double; Painful neck; Felt like cold coming on; Rash on right arm; Headache/Painful back of head; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep6955) via an unspecified route of administration in the arm right on 27Mar2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included daily vitamin (MANUFACTURER UNKNOWN),  airborne gummies and vitamin D3 (MANUFACTURER UNKNOWN) for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, patient was shot in right arm and experienced sore arm. On 28Mar2021, the patient experienced rash (in past few days) a weird rash was appearing in random areas for a day, rash on right arm/rash on lower back, arms, legs, torso, chest, feet and headache/painful back of head. On 29Mar2021 at 12:00, the patient felt like cold coming on. On 30Mar2021, the patient experienced painful neck, experienced sleeping double what she usually sleeps (16 hours instead of 8 hours) and extreme tiredness/fatigue. The event resulted in emergency room/department or urgent care. On 05Apr2021, the patient went to urgent care, they even thought she had caught COVID at the same time as getting the vaccine and checked with nasal swab test but the test came back negative. Therapeutic measures were taken as a result of neck pain which included treatment with ketorolac (MANUFACTURER UNKNOWN). The clinical outcome of the event sore arm, rash on right arm/rash on lower back, arms, legs, torso, chest, feet, felt like cold coming on, headache/painful back of head, painful neck, sleeping double and extreme tiredness/fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, SARS-CoV-2 test
Clinical narrative: Extreme tiredness/fatigue; Sleeping double; Painful neck; Felt like cold coming on; Rash on right arm; Headache/Painful back of head; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep6955) via an unspecified route of administration in the arm right on 27Mar2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included daily vitamin (MANUFACTURER UNKNOWN),  airborne gummies and vitamin D3 (MANUFACTURER UNKNOWN) for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, patient was shot in right arm and experienced sore arm. On 28Mar2021, the patient experienced rash (in past few days) a weird rash was appearing in random areas for a day, rash on right arm/rash on lower back, arms, legs, torso, chest, feet and headache/painful back of head. On 29Mar2021 at 12:00, the patient felt like cold coming on. On 30Mar2021, the patient experienced painful neck, experienced sleeping double what she usually sleeps (16 hours instead of 8 hours) and extreme tiredness/fatigue. The event resulted in emergency room/department or urgent care. On 05Apr2021, the patient went to urgent care, they even thought she had caught COVID at the same time as getting the vaccine and checked with nasal swab test but the test came back negative. Therapeutic measures were taken as a result of neck pain which included treatment with ketorolac (MANUFACTURER UNKNOWN). The clinical outcome of the event sore arm, rash on right arm/rash on lower back, arms, legs, torso, chest, feet, felt like cold coming on, headache/painful back of head, painful neck, sleeping double and extreme tiredness/fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Chest discomfort, Chills, Dizziness
Clinical narrative: Eye pressure; Headache; Abdominal ache; Heavy chest; Chills; 100 fever; Aches; Dizziness; Fog brain; Study runny nose; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 17:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included obese and penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took ceftriaxone (MANUFACTURER UNKNOWN) and trimethoprim, sulfamethoxazole (BACTRIM) and experienced allergy. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 17:15, immediately after the vaccine the patient experienced dizziness, fog brain and late at night, the patient was tired and had study runny nose. On 02Apr2021, the patient experienced 100 fever, aches and chills. On 03Apr2021, the patient experienced abdominal ache, heavy chest and on 04Apr2021, the patient experienced heavy chest, eye pressure and headache. On 02Apr2021, the patient underwent lab tests which included body temperature and the resulted with a temperature of 100(unspecified unit). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  The clinical outcome of the events dizziness, fog brain, tired, study runny nose, 100 fever, aches, chills, abdominal ache, heavy chest, eye pressure and headache were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Ocular discomfort, Pain
Clinical narrative: Eye pressure; Headache; Abdominal ache; Heavy chest; Chills; 100 fever; Aches; Dizziness; Fog brain; Study runny nose; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 17:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included obese and penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took ceftriaxone (MANUFACTURER UNKNOWN) and trimethoprim, sulfamethoxazole (BACTRIM) and experienced allergy. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 17:15, immediately after the vaccine the patient experienced dizziness, fog brain and late at night, the patient was tired and had study runny nose. On 02Apr2021, the patient experienced 100 fever, aches and chills. On 03Apr2021, the patient experienced abdominal ache, heavy chest and on 04Apr2021, the patient experienced heavy chest, eye pressure and headache. On 02Apr2021, the patient underwent lab tests which included body temperature and the resulted with a temperature of 100(unspecified unit). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  The clinical outcome of the events dizziness, fog brain, tired, study runny nose, 100 fever, aches, chills, abdominal ache, heavy chest, eye pressure and headache were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: Eye pressure; Headache; Abdominal ache; Heavy chest; Chills; 100 fever; Aches; Dizziness; Fog brain; Study runny nose; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 17:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included obese and penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took ceftriaxone (MANUFACTURER UNKNOWN) and trimethoprim, sulfamethoxazole (BACTRIM) and experienced allergy. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 17:15, immediately after the vaccine the patient experienced dizziness, fog brain and late at night, the patient was tired and had study runny nose. On 02Apr2021, the patient experienced 100 fever, aches and chills. On 03Apr2021, the patient experienced abdominal ache, heavy chest and on 04Apr2021, the patient experienced heavy chest, eye pressure and headache. On 02Apr2021, the patient underwent lab tests which included body temperature and the resulted with a temperature of 100(unspecified unit). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  The clinical outcome of the events dizziness, fog brain, tired, study runny nose, 100 fever, aches, chills, abdominal ache, heavy chest, eye pressure and headache were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: Chills; Fever/low grade fever; Nausea; Muscle aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 27Mar2021 at 10:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, graves' disease, hyperparathyroidism, Afib (atrial fibrillation) and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), latanoprost (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) and baby aspirin (MANUFACTURER UNKNOWN) had received within 2 weeks of vaccination for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. One week after the vaccination, on 03Apr2021 at 10:00, the patient experienced chills, fever/low-grade fever, nausea, muscle aches and fatigue. The next day, the patient still had low-grade fever and fatigue. The patient still felt off for a couple more days. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. On 05Apr2021, the patient underwent a PCR test (nasal swab test) and the result was negative. The clinical outcome of the events chills, fever/low-grade fever, nausea, muscle aches and fatigue was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Chills; Fever/low grade fever; Nausea; Muscle aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 27Mar2021 at 10:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, graves' disease, hyperparathyroidism, Afib (atrial fibrillation) and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), latanoprost (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) and baby aspirin (MANUFACTURER UNKNOWN) had received within 2 weeks of vaccination for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. One week after the vaccination, on 03Apr2021 at 10:00, the patient experienced chills, fever/low-grade fever, nausea, muscle aches and fatigue. The next day, the patient still had low-grade fever and fatigue. The patient still felt off for a couple more days. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. On 05Apr2021, the patient underwent a PCR test (nasal swab test) and the result was negative. The clinical outcome of the events chills, fever/low-grade fever, nausea, muscle aches and fatigue was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Memory impairment, Nausea
Clinical narrative: 4 days after vaccine started light headed; 4 days after vaccine had a lot of trouble remembering things; 4 days after vaccine started feeling tired; 4 days after vaccine started feeling nauseous; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 29Mar2021 at 05:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and allergic to gluten (just gluten due to celiac but it's very well managed). Concomitant medications included paracetamol (TYLENOL 500mg) taken 4 days later when symptoms started (06Apr2021) for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 14:00, the patient started to feeling tired, nauseous, light headed and had a lot of trouble remembering things. The patient still feeling that way 4 days after the onset of symptoms. The patient reported that she was unsure if related to vaccine but she knows one other person in the same situation, which she felt was enough to make her question. The patient wants to know whether the vaccine was safe to get her second dose if it was vaccine abs. The patient reported that she figured that she could just sleep it off abs be fine but its still lingering and memory loss part is worrisome. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of started to feeling tired, nauseous, light headed and had a lot of trouble remembering things not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Insomnia, Poor quality sleep
Clinical narrative: Insomnia - hard to fall asleep; hard to stay asleep; wake too early; constant exhaustion; periodic dizziness; diminished appetite; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 13:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy on an unknown date. Concomitant medications included biotin (MANUFACTURER UNKNOWN), vitamin D nos (VITAMIN D), curcuma longa (TURMERIC) and silicon dioxide (VIVISCAL); all from unknown dates for unknown indications. The patient previously took Diflucan on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 16:00 the patient experienced insomnia - hard to fall asleep, hard to stay asleep, wake too early, constant exhaustion, periodic dizziness diminished appetite. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment with Trazadone 50 mg. The clinical outcome of the events insomnia - hard to fall asleep, hard to stay asleep, wake too early, constant exhaustion, periodic dizziness diminished appetite was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Terminal insomnia
Clinical narrative: Insomnia - hard to fall asleep; hard to stay asleep; wake too early; constant exhaustion; periodic dizziness; diminished appetite; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 13:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy on an unknown date. Concomitant medications included biotin (MANUFACTURER UNKNOWN), vitamin D nos (VITAMIN D), curcuma longa (TURMERIC) and silicon dioxide (VIVISCAL); all from unknown dates for unknown indications. The patient previously took Diflucan on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 16:00 the patient experienced insomnia - hard to fall asleep, hard to stay asleep, wake too early, constant exhaustion, periodic dizziness diminished appetite. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment with Trazadone 50 mg. The clinical outcome of the events insomnia - hard to fall asleep, hard to stay asleep, wake too early, constant exhaustion, periodic dizziness diminished appetite was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Persistent lightheadedness/dizziness; vertigo; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 24Mar2021 at 02:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 the patient experienced Persistent light headedness, dizziness, vertigo. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vertigo, light headedness was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: Started spotting one week after the first dose of the vaccine.; This is a spontaneous report from a contactable consumer. A 18-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 27Mar2021 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID -19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food or other products. Concomitant medications included ethinylestradiol, norgestrel (CRYSELLE) and birth control; all from an unknown date for unknown indication. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On 05Apr2021, the patient experienced spotting menstrual one week after the first dose of the vaccine. The patient menstrual cycle had changed. The patient was on birth control and had never spotted while using pill. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of spotting menstrual was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache
Clinical narrative: Shortness of breath for more than 2 days (5 days so far); dizziness; severe headaches; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome, transient ischemic attack, asthma, and penicillin allergy. Concomitant medication included bupropion hydrochloride (WELLBUTRIN XL) from an unknown date, for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 17:00 the patient experienced shortness of breath for more than two days (5 days so far), dizziness, and severe headache. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events of shortness of breath, dizziness, and severe headache were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Seemingly extreme pain in arm, where functionally lifting arm becomes impaired at certain angles and directions.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Impaired work ability, Myalgia
Clinical narrative: Starting on June 27,2021 and continuing to present: severe muscle and joint pain, severe nausea/vomiting, severe fatigue, respiratory congestion, sinus congestion, SOB, racing heartbeat . Respiratory and sinus congestion, SOB, and racing heartbeat have been coming and going over the time indicate. Due to severity and prolonged symptoms I have been unable to work.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Palpitations, Respiratory tract congestion, Sinus congestion, Vomiting
Clinical narrative: Starting on June 27,2021 and continuing to present: severe muscle and joint pain, severe nausea/vomiting, severe fatigue, respiratory congestion, sinus congestion, SOB, racing heartbeat . Respiratory and sinus congestion, SOB, and racing heartbeat have been coming and going over the time indicate. Due to severity and prolonged symptoms I have been unable to work.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Pain, SARS-CoV-2 test positive
Clinical narrative: Patient develop symptoms of cough, fatigue, and body aches on 07/26.  She tested positive for COVID on 7/28/21
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: patient had a COVID test for pre travel purposes on 7/28/2021, which came back positive
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hyperhidrosis, Nausea
Clinical narrative: Severe nausea and lightheaded and sweating mild headache  for 1 week
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Myalgia, Rhinorrhoea
Clinical narrative: patient developed cough, fatigue, muscle aches, and runny nose on 7/27/2021.  He tested positive for COVID on 7/28/2021
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: patient developed cough, fatigue, muscle aches, and runny nose on 7/27/2021.  He tested positive for COVID on 7/28/2021
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Chills; Fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm right on 29Mar2021 at 09:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient received unspecified medications within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm right on 08Mar2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 01:00, the patient experienced chills, fever, fatigue and headache. No therapeutic measures were taken as a result of events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events chills, fever, fatigue and headache were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Vomiting
Clinical narrative: fever; chills; aching; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 15:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications were not reported. The patient has known allergies to tree nuts. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Mar2021 at 15:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation and also received sulfa drugs and was allergic to it.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 07Apr2021 at 04:30, the patient experienced fever, chills, aching and vomiting. the events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills, aching and vomiting were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: has broken to hives; This is a spontaneous report from a contactable pharmacist. A 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an intramuscular route of administration in the left arm on 31Mar2021 at 01:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was unknown and also unknown if the patient received any other medications within 2 weeks of vaccination. It was unknown if the patient was pregnant at the time of vaccination and also unknown if the patient had any allergies to medications, food, or other products. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient had broken to hives. The event resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the event and included treatment with prednisone tablet (tab). The clinical outcome of the event broken to hives was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Pruritus, Sleep disorder, Urticaria
Clinical narrative: has broken to hives; This is a spontaneous report from a contactable pharmacist. A 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an intramuscular route of administration in the left arm on 31Mar2021 at 01:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was unknown and also unknown if the patient received any other medications within 2 weeks of vaccination. It was unknown if the patient was pregnant at the time of vaccination and also unknown if the patient had any allergies to medications, food, or other products. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient had broken to hives. The event resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the event and included treatment with prednisone tablet (tab). The clinical outcome of the event broken to hives was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Insomnia, Nausea, Pain in extremity
Clinical narrative: Temperature at 99.2 F at noon today; Moderate to severe diarrhea beginning the morning after injection.; Pain in the upper left arm around the injection site. Wosened over night.; Pain when using arm.; Light nausea; Unable to sleep on the left side because of this.; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, IBS, ADHD and depression. Concomitant medications included methylphenidate 54 (MANUFACTURER UNKNOWN) and fluoxetine 50 (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 13:00, the patient experienced pain in the upper left arm around the injection site, worsening with pressure beyond the expected level for an injection that worsened over night, pain when using arm, unable to sleep on the left side because of pain and light nausea. On 07Apr2021, the patient experienced moderate to severe diarrhea beginning the morning after injection. Despite having IBS, it was not accompanied with the intense cramps that an IBS episode usually would have. On 07Apr2021 at noon, the body temperature was reported as 99.2 F (Fahrenheit). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events moderate to severe diarrhea, pain in the upper left arm around the injection site, pain when using arm, unable to sleep on the left side because of pain, light nausea and temperature at 99.2 F was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Temperature at 99.2 F at noon today; Moderate to severe diarrhea beginning the morning after injection.; Pain in the upper left arm around the injection site. Wosened over night.; Pain when using arm.; Light nausea; Unable to sleep on the left side because of this.; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, IBS, ADHD and depression. Concomitant medications included methylphenidate 54 (MANUFACTURER UNKNOWN) and fluoxetine 50 (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 13:00, the patient experienced pain in the upper left arm around the injection site, worsening with pressure beyond the expected level for an injection that worsened over night, pain when using arm, unable to sleep on the left side because of pain and light nausea. On 07Apr2021, the patient experienced moderate to severe diarrhea beginning the morning after injection. Despite having IBS, it was not accompanied with the intense cramps that an IBS episode usually would have. On 07Apr2021 at noon, the body temperature was reported as 99.2 F (Fahrenheit). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events moderate to severe diarrhea, pain in the upper left arm around the injection site, pain when using arm, unable to sleep on the left side because of pain, light nausea and temperature at 99.2 F was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity
Clinical narrative: Chills; Body ache; Tired; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 06Apr2021 at 14:30(at the age of 48-year-old) as a single dose for COVID-19 immunisation. The patient had no known medical history. Concomitant medications included famotidine (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) from unknown date for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 15Mar2021 at 10:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation and took AFRIN on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received the first dose of COVID-19 vaccine within four weeks prior to the vaccination. On 07Apr2021 at 03:00 the patient experienced chills, body ache, tired and sore arm. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events chills, body ache, tired and sore arm were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Fever of 100.5; Chills; This is a spontaneous report received from a non-contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150 ) via an unspecified route of administration in the arm left on 06Apr2021 at 10:00 as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies. The patient did not receive any medications two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6267) via an unspecified route of administration in the arm left on 14Apr2021 at 17:30, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, the patient had a fever of 100.5 and chills. It was unknown whether any therapeutic measures were taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events fever of 100.5 and chills was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.